Tag: Viral therapy

Jean-Simon Diallo

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Associate Scientist, Faculty of Medicine, University of Ottawa   Full Biography   Cancers of Interest Sarcoma Prostate Breast   Research Interests and Clinical Approach Oncolytic Virotherapy Viral sensitizers Combination Immunotherapy   Projects at BioCanRx Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer… Read more »

Gregory Dekaban

Robarts Scientist and Professor, Western University   Full Biography   Cancers of Interest Blood Prostate   Projects at BioCanRx In vivo human therapeutic cell tracking using a [19F]-perfluorocarbon cellular MRI contrast agent: Phase I feasibility and preliminary safety trial

Christopher Boddy

Director, Biochemistry Program and Full Professor, University of Ottawa   Full Biography   Cancers of Interest Breast Colorectal Kidney Liver   Projects at BioCanRx Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization

Jonathan Bramson

Professor, McMaster University Department of Pathology and Molecular Medicine Vice-Dean, Research, Faculty of Health Sciences, McMaster University Director, Fraunhofer Project Centre for Biomedical Engineering and Advanced Manufacturing Canada Research Chair in Translational Cancer Immunology John Bienenstock Chair in Molecular Medicine   Full Biography   Cancers of Interest Bone Breast Lung   Projects at BioCanRx Phase… Read more »

John Bell

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Professor, Depts. of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa Program Director, Ontario Regional Biotherapeutics Program(ORBiT), Ontario Institute for Cancer Research, OICR Director, Canadian Oncolytic Virus Consortium (COVCo), Terry Fox New Frontiers Program Project Grant Scientific Director, BioCanRx, Biotherapeutics for Cancer Treatment, Network of… Read more »

Rebecca Auer

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Professor, Department of Surgery and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa Surgical Oncologist, Faculty of Medicine, Department of Biochemistry, Immunology & Microbiology, The Ottawa Hospital Tier 2 Clinical Research Chair, Perioperative Cancer Therapeutics, University of Ottawa Scientific Director, Cancer Therapeutics… Read more »